Literature DB >> 20083850

Modulation of corticotropin releasing factor (CRF) signaling through receptor splicing in mouse pituitary cell line AtT-20--emerging role of soluble isoforms.

M A Zmijewski1, A T Slominski.   

Abstract

Previously, using cultured human epidermal keratinocytes we have demonstrated that the activity of CRF1 receptor can be modulated by the process of alternative splicing. This phenomenon has been further investigated in the mouse corticotroph AtT-20 cell line. In the cells, transiently transfected with the plasmids coding human CRF1 isoforms, only isoforms alpha and c have shown expression on the cell membrane. Other isoforms d, e, g and h had intracellular localization with the isoform e also found in the nucleus. Co-expression of the CRF1alpha (main form of the receptor) with isoforms d, f and g prevented its expression on the cell surface resulting in accumulation of CRF1alpha inside of the cell. s expected, CRF stimulated time and dose dependent activation of CRE, CARE, AP-1 transcription elements and POMC promoter in AtT-20 cells overexpressing human CRF1alpha, while having no effect on the AP-1 transcriptional activity in cells transfected with other isoforms (d, f, g and h). However, when cells were co-transfected with CRF1alpha and CRF1e or h the CRF stimulated transcriptional activity of CRE and AP-1 was amplified in comparison to the cells expressing solely CRF1alpha; the effect was more pronounced for CRF1h than for CRF1e. In contrast, the conditioned media from the cells overexpressing CRF1e and h inhibited the CRF induced transcriptional activity in cells overexpressing CRF1alpha. Media from cells expressing CRF1h were significantly more potent that from cells transfected with CRF1e. In summary, we have demonstrated that alternatively spliced CRF1 isoforms can regulate the cellular localization of CRF1alpha, and that soluble CRF1 isoforms can have a dual effect on CRF1alpha activity depending on the intracellular vs. extracellular localization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20083850      PMCID: PMC2814449     

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  35 in total

1.  A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes.

Authors:  D K Grammatopoulos; Y Dai; H S Randeva; M A Levine; E Karteris; A J Easton; E W Hillhouse
Journal:  Mol Endocrinol       Date:  1999-12

Review 2.  Corticotropin releasing factor receptors and their ligand family.

Authors:  M H Perrin; W W Vale
Journal:  Ann N Y Acad Sci       Date:  1999-10-20       Impact factor: 5.691

Review 3.  GPCR monomers and oligomers: it takes all kinds.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Trends Neurosci       Date:  2008-01-15       Impact factor: 13.837

Review 4.  Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress.

Authors:  A Slominski; J Wortsman; T Luger; R Paus; S Solomon
Journal:  Physiol Rev       Date:  2000-07       Impact factor: 37.312

5.  Prostaglandins and interleukin-1beta in the hypothalamic-pituitary-adrenal response to systemic phenylephrine under basal and stress conditions.

Authors:  A Gadek-Michalska; A J Bugajski; J Bugajski
Journal:  J Physiol Pharmacol       Date:  2008-09       Impact factor: 3.011

6.  Expression of corticotropin-releasing hormone receptor type 1 and type 2 in human pregnant myometrium.

Authors:  Dan Jin; Ping He; Xingji You; Xiaoyan Zhu; Ling Dai; Qian He; Chunmin Liu; Ning Hui; Jinyan Sha; Xin Ni
Journal:  Reprod Sci       Date:  2007-09       Impact factor: 3.060

7.  Nitric oxide in the adrenergic-and CRH-induced activation of hypothalamic-pituitary-adrenal axis.

Authors:  A Gadek-Michalska; J Bugajski
Journal:  J Physiol Pharmacol       Date:  2008-06       Impact factor: 3.011

8.  Alternative splicing of the G protein-coupled receptor superfamily in human airway smooth muscle diversifies the complement of receptors.

Authors:  Richard Einstein; Heather Jordan; Weiyin Zhou; Michael Brenner; Esther G Moses; Stephen B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-24       Impact factor: 11.205

9.  Dimerization of the class A G protein-coupled neurotensin receptor NTS1 alters G protein interaction.

Authors:  Jim F White; Justin Grodnitzky; John M Louis; Loc B Trinh; Joseph Shiloach; Joanne Gutierrez; John K Northup; Reinhard Grisshammer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-09       Impact factor: 11.205

10.  CRF1 receptor splicing in epidermal keratinocytes: potential biological role and environmental regulations.

Authors:  Michal A Zmijewski; Andrzej T Slominski
Journal:  J Cell Physiol       Date:  2009-03       Impact factor: 6.384

View more
  12 in total

Review 1.  Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction.

Authors:  Dimitris K Grammatopoulos
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Neuroendocrinology of the skin: An overview and selective analysis.

Authors:  Michal A Zmijewski; Andrzej T Slominski
Journal:  Dermatoendocrinol       Date:  2011-01

Review 3.  Consequences of splice variation on Secretin family G protein-coupled receptor function.

Authors:  Sebastian G B Furness; Denise Wootten; Arthur Christopoulos; Patrick M Sexton
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 4.  Function of alternative splicing.

Authors:  Olga Kelemen; Paolo Convertini; Zhaiyi Zhang; Yuan Wen; Manli Shen; Marina Falaleeva; Stefan Stamm
Journal:  Gene       Date:  2012-08-15       Impact factor: 3.688

Review 5.  Emerging role of alternative splicing of CRF1 receptor in CRF signaling.

Authors:  Michał A Zmijewski; Andrzej T Slominski
Journal:  Acta Biochim Pol       Date:  2010-03-16       Impact factor: 2.149

Review 6.  Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Cezary Skobowiat; Blazej Zbytek; Radomir M Slominski; Jeffery D Steketee
Journal:  Adv Anat Embryol Cell Biol       Date:  2012       Impact factor: 1.231

Review 7.  The CRF System as a Therapeutic Target for Neuropsychiatric Disorders.

Authors:  Jeff Sanders; Charles Nemeroff
Journal:  Trends Pharmacol Sci       Date:  2016-10-04       Impact factor: 14.819

Review 8.  Key role of CRF in the skin stress response system.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Blazej Zbytek; Desmond J Tobin; Theoharis C Theoharides; Jean Rivier
Journal:  Endocr Rev       Date:  2013-08-12       Impact factor: 19.871

9.  Antisense-mediated isoform switching of steroid receptor coactivator-1 in the central nucleus of the amygdala of the mouse brain.

Authors:  Ioannis Zalachoras; Gwendolynn Grootaers; Lisa T C M van Weert; Yves Aubert; Suzanne R de Kreij; Nicole A Datson; Willeke M C van Roon-Mom; Annemieke Aartsma-Rus; Onno C Meijer
Journal:  BMC Neurosci       Date:  2013-01-07       Impact factor: 3.288

10.  Antisense-mediated RNA targeting: versatile and expedient genetic manipulation in the brain.

Authors:  Ioannis Zalachoras; Melvin M Evers; Willeke M C van Roon-Mom; Annemieke M Aartsma-Rus; Onno C Meijer
Journal:  Front Mol Neurosci       Date:  2011-07-19       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.